Innovative AI Platform Exer AI leverages advanced computer vision and machine learning technologies to provide accurate, validated motion assessments without sensors or wearables, making their solutions highly adaptable for diverse clinical settings including remote and in-person care.

Strategic Partnerships Recent collaboration with Mayo Clinic demonstrates Exer AI's credibility and potential to expand its platform's diagnostic and therapeutic capabilities, opening opportunities to engage other leading healthcare institutions seeking innovative movement disorder solutions.

Funding & Growth With over $6.5 million raised in recent funding rounds and a revenue range of 1 to 10 million dollars, Exer AI is positioned for scaling its clinical offerings, providing a compelling opportunity to offer complementary products or services to accelerate growth.

Expanding Clinical Use Exer AI has developed multiple applications, including Gait and Physio, targeting various rehabilitation and movement assessment needs across disciplines, presenting sales opportunities for integrating with rehabilitation clinics, physical therapists, and specialized care providers.

Industry Alignment Operating in the health care and hospitals industry, with a focus on musculoskeletal and movement disorder diagnostics, Exer AI is well-positioned to partner with hospitals, health systems, and specialized clinics looking to adopt AI-driven, remote patient monitoring solutions for improved clinical outcomes.